Photography by Matt Breneman
The 2nd Annual Getzlaf Golf Shootout was held recently at Monarch Beach Golf Links in Dana Point to benefit CureDuchenne. Ryan Getzlaf, captain of the Anaheim Ducks, hosted the second annual event to benefit CureDuchenne, a nonprofit based in Newport Beach, that raises awareness and funds research to find a cure for Duchenne muscular dystrophy. Anaheim Ducks and Los Angeles Kings hockey players, celebrities and community leaders will participate in the golf outing to support finding a cure for Duchenne, a devastating muscle disease that impacts one in 3,500 boys.
Athletes and celebrities who participated included Bobby Ryan, Anaheim Ducks; Teemu Selanne, Anaheim Ducks; Sheldon Souray, Anaheim Ducks; Scott Neidermayer, Anaheim Ducks (retired); Dustin Penner, Los Angeles Kings; Mike Richards, Los Angeles Kings; Bruce Boudreau, coach of the Anaheim Ducks; Kent French, the voice of the Anaheim Ducks; Paul Bissonnette, Phoenix Coyotes; and actor Kevin Connolly.
A pre-golf dinner reception was held at Sutra in Costa Mesa on September 8 and included a silent and live auction and pledge program. The 2nd Annual Getzlaf Golf Shootout raised nearly $200,000 for CureDuchenne.
Boys with Duchenne are usually diagnosed at age 5, are in a wheelchair by 12 and most don’t live past their mid-20s. CureDuchenne has funded seven research projects that have gone into human clinical trials. CureDuchenne supports the translation of research and development programs into the clinic to focus on developing potential therapies to transform the treatment of Duchenne.
“My wife, Paige, and I are happy to continue our support for CureDuchenne and their valued efforts in finding a cure for Duchenne,” said Getzlaf. “We can’t imagine what it would be like for our son to grow up and not to be able to walk, run or play sports. We want to provide help for Duchenne boys for many generations to come.”
“We are delighted that CureDuchenne is the beneficiary of the Getzlaf Golf Shootout and thank Ryan and Paige for their support,” said Debra Miller, founder and CEO of CureDuchenne. “Duchenne is a progressive disease and it is urgent that we find treatments now.”
CureDuchenne has garnered international attention for its efforts to raise funds and awareness for Duchenne. With the help of CureDuchenne’s distinguished international panel of Scientific Advisors, funds raised by CureDuchenne support the most promising research aimed at treating and curing Duchenne. To date, seven CureDuchenne research projects have made their way into human clinical trials – a unique accomplishment as few health-related nonprofits have been successful in being a catalyst for human clinical trials.